“The apprehension with employing non IID mentioned ingredients is justified as it can be not possible to evaluate if FDA would locate the ‘novel excipient’ Secure for use in the drug product or service as there's no described procedure for evaluation and acceptance of excipients. The FDA steering on https://derricku279vuq2.yourkwikimage.com/user